Olink Holding AB (publ) at JPMorgan Healthcare Conference (Virtual) Transcript
Good morning, everyone. Welcome to day 3 of the JPMorgan Healthcare Conference. This is [Julia Ching] from Life Science team at JPMorgan, and it's my great pleasure to introduce you to our next company presentation by Olink.
Just as a reminder, if you have a question, you can submit it through the website. And with that, let me turn it over to Jon.
()-&
Thank you very much, Julia, and good morning, everyone. Firstly, I want to thank our dear friends at JPMorgan inviting me to present here today. I really look forward to meeting all of you in person and have planned for an in-person event, but very much appreciate the invitation and the opportunity to speak with everyone here today.
My name is Jon Heimer. This year, I complete 30 years as a serial entrepreneur in the biotech device and drug development space. I was part of founding Olink in 2016 and been its CEO since inception.
I reminded to everyone today that I'll be
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |